142 related articles for article (PubMed ID: 31898656)
1. Interdigitated versus sequential high-dose-rate intracavitary brachytherapy with external beam radiotherapy in locally advanced carcinoma cervix.
Alam N; Akram M; Siddiqui SA; Hussain MAB
J Cancer Res Ther; 2019; 15(6):1254-1259. PubMed ID: 31898656
[TBL] [Abstract][Full Text] [Related]
2. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract][Full Text] [Related]
4. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
5. Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study.
Kumar P; Sharma DN; Kumar S; Gandhi AK; Rath GK; Julka PK
Brachytherapy; 2016; 15(3):327-332. PubMed ID: 26996595
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
7. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
8. To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities.
Gadda IR; Khan NA; Wani SQ; Baba MH
J Cancer Res Ther; 2022; 18(3):740-746. PubMed ID: 35900548
[TBL] [Abstract][Full Text] [Related]
9. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
11. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of extended field radiation therapy in Stage III carcinoma cervix versus conventional field techniques: A comparative study.
Daga P; Kumar HS; Sharma N; Jakhar SL; Harsh KK; Dhaka S
J Cancer Res Ther; 2022; 18(4):1083-1087. PubMed ID: 36149164
[TBL] [Abstract][Full Text] [Related]
14. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
[TBL] [Abstract][Full Text] [Related]
16. Rapid involution and mobility of carcinoma of the cervix.
Lee CM; Shrieve DC; Gaffney DK
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):625-30. PubMed ID: 14751536
[TBL] [Abstract][Full Text] [Related]
17. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis.
Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Sankar AS; Mallick I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):46-51. PubMed ID: 16477919
[TBL] [Abstract][Full Text] [Related]
18. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
19. Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: Results of a prospective randomized phase III trial.
Sharma M; Revannasiddaiah S; Gupta M; Seam RK; Gupta MK; Rastogi M
J Cancer Res Ther; 2016; 12(1):103-8. PubMed ID: 27072219
[TBL] [Abstract][Full Text] [Related]
20. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]